Clinical Trials Browser

Phase 1 × Aminolevulinic Acid × CNS × Clear all

NCT06665724 2026-02-27

Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Phase 1 Completed

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT02191488 2025-09-15

ALA-induced PpIX Fluorescence During Brain Tumor Resection

Phase 1 Active not recruiting

Brain Neoplasms, Glioma

NCT05362409 2025-06-19

Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT01682811 2021-06-18

Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

Phase 1 Completed

20 enrolled 11 charts

Neurofibromatoses

NCT00870779 2019-06-14

FGR

Phase 1 Completed

Brain Neoplasms, Glioma, Meningioma, Pituitary Neoplasms, Skull Base Neoplasms

NCT01148966 2017-02-15

Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors

Phase 1 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT01502605 2017-01-05

Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas

Phase 1 Terminated

Astrocytoma, Brain Neoplasms, Glioma

NCT00671710 2011-01-14

Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain

Phase 1 Completed

Brain Neoplasms